Open access
Sep 2026
Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany
Lowering the adult vaccination age enhanced the epidemiological impact of pneumococcal vaccination in Germany, with V116 showing the greatest overall reductions in disease.
O. Sharomi, M. de Lepper, Lisa M. Lang et al.
· Human Vaccines & Immunothera... · 0 citations